Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.9100
-0.0100
(-0.52%)
At close: April 1 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.05 | -0.05 | -0.16 | 0.03 |
| Low Estimate | -0.05 | -0.06 | -0.26 | -0.28 |
| High Estimate | -0.04 | -0.04 | -0.06 | 0.33 |
| Year Ago EPS | -0.08 | -0.04 | -0.33 | -0.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 44.88M | 44.63M | 192.37M | 275.54M |
| Low Estimate | 41.8M | 42.05M | 176.9M | 212.5M |
| High Estimate | 46.4M | 46.55M | 224.46M | 365.33M |
| Year Ago Sales | 32.61M | 43.65M | 160.18M | 192.37M |
| Sales Growth (year/est) | 37.65% | 2.24% | 20.10% | 43.23% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.05 | -0.05 | -0.08 |
| EPS Actual | -0.08 | -0.04 | -0.1 | -0.1 |
| Difference | 0.01 | 0.01 | -0.05 | -0.03 |
| Surprise % | 6.33% | 20.00% | -100.00% | -33.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.05 | -0.16 | 0.03 |
| 7 Days Ago | -0.04 | -0.05 | -0.15 | 0.05 |
| 30 Days Ago | -0.05 | -0.05 | -0.14 | 0.1 |
| 60 Days Ago | -0.05 | -0.05 | -0.14 | 0.1 |
| 90 Days Ago | -0.08 | -0.07 | -0.19 | 0.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AKBA | 46.62% | -25.00% | 50.97% | 115.63% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 4/1/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 3/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/23/2024 |
Related Tickers
AQST Aquestive Therapeutics, Inc.
2.8600
-1.38%
ESPR Esperion Therapeutics, Inc.
1.4100
-2.08%
BCRX BioCryst Pharmaceuticals, Inc.
7.25
-3.33%
IRWD Ironwood Pharmaceuticals, Inc.
1.4100
-4.08%
SCYX SCYNEXIS, Inc.
0.9424
-1.02%
CYTH Cyclo Therapeutics, Inc.
0.7206
0.00%
DVAX Dynavax Technologies Corporation
12.71
-2.00%
AMRX Amneal Pharmaceuticals, Inc.
8.23
-1.79%
RMTI Rockwell Medical, Inc.
1.0800
-4.42%
ETON Eton Pharmaceuticals, Inc.
12.76
-1.69%